Related Experiment Video
Updated: Jul 5, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Matrix metalloproteinase inhibitors
1Medicinal Chemistry Division, 224 School of Pharmacy, University of Wisconsin-Madison, 425 N Charter Street, Madison, WI 53706, USA. yzhang12@students.wisc.edu
Abstract:
The Division of Medicinal Chemistry offered a number of sub-sessions including this one on matrix metalloproteinase (MMP) inhibitors. The overexpression of matrix metalloproteinases has been associated with cancer malignancy, arthritis and several immune system-related infectious diseases such as sepsis. Encouraged by the impressive clinical trials of batimastat and marimastat (Figure 1; British Biotech plc), interest in MMP inhibitors has grown.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
MicroRNAs
MicroRNAs

